|
Study identifies another strategy for normalizing tumor blood supply
February 21, 2008Controlling nitric oxide levels could further improve effectivness of anticancer therapies
Manipulating levels of nitric oxide (NO), a gas involved in many biological processes, may improve the disorganized network of blood vessels supplying tumors, potentially improving the effectiveness of radiation and chemotherapy. In an upcoming issue of the journal Nature Medicine, researchers from the Steele Laboratory of Radiation Oncology at Massachusetts General Hospital (MGH) report an experiment in which NO production was selectively suppressed in tumor cells while being maintained in blood vessels. The result was a significant improvement in the appearance and function of the tumor's blood supply.
"Our finding suggest that the creation of perivascular NO gradients - differences between the levels produced in blood vessels and those found in tumor tissue - may be able to normalize tumor vasculature," says Dai Fukumura, MD, PhD, of the Steele Laboratory, who led the study. "Combining the use of angiogenesis inhibitors, which normalize vasculature through a different mechanism, with the blockade of nonvascular NO production may produce even greater improvement in therapeutic outcomes."
The blood vessels that develop around and within tumors are leaky and disorganized, interfering with delivery of chemotherapy drugs and with radiation treatment, which requires an adequate oxygen supply. Combining angiogenesis inhibitors, drugs that suppress the growth of blood vessels, with traditional anticancer therapies has improved patient survival in some tumors. That success supports a theory developed by Rakesh K. Jain, PhD, director of the Steele Laboratory, that the agents temporarily 'normalize' blood vessels, creating a period during which other treatments can be more effective.
Since angiogenesis is one of many physiologic activities mediated by NO, the MGH research team hypothesized that restricting NO production to blood vessels also could improve tumor vasculature. Using cancer cells from human brain tumors, they suppressed the enzyme that controls NO production in nonvascular tissue. When the modified tumor cells were implanted into mice, analysis of the resulting tumors showed that NO was present primarily in blood vessels, with significant reductions in tumor cells. Vessels in the growing tumors were more evenly distributed and less distorted than those in tumors grown from untreated tissue.
"Angiogenesis inhibitors block formation of new vessels by directly or indirectly inhibiting the proliferation and survival of vascular endothelial cells. But since their overall effect is to reduce the density of blood vessels, the ability of those agents to normalize tumor vasculature may not last long," says Fukumura. "Blocking nonvascular NO production and maintaining NO levels around the vessels appears to keep endothelial cell function at the proper level." An associate professor of Radiation Oncology at Harvard Medical School, Fukumura notes that the strategy now should be investigated in other types of tumors.
Massachusetts General Hospital
The blood vessels that develop around and within tumors are leaky and disorganized, interfering with delivery of chemotherapy drugs and with radiation treatment, which requires an adequate oxygen supply. Combining angiogenesis inhibitors, drugs that suppress the growth of blood vessels, with traditional anticancer therapies has improved patient survival in some tumors. That success supports a theory developed by Rakesh K. Jain, PhD, director of the Steele Laboratory, that the agents temporarily 'normalize' blood vessels, creating a period during which other treatments can be more effective.
Since angiogenesis is one of many physiologic activities mediated by NO, the MGH research team hypothesized that restricting NO production to blood vessels also could improve tumor vasculature. Using cancer cells from human brain tumors, they suppressed the enzyme that controls NO production in nonvascular tissue. When the modified tumor cells were implanted into mice, analysis of the resulting tumors showed that NO was present primarily in blood vessels, with significant reductions in tumor cells. Vessels in the growing tumors were more evenly distributed and less distorted than those in tumors grown from untreated tissue.
"Angiogenesis inhibitors block formation of new vessels by directly or indirectly inhibiting the proliferation and survival of vascular endothelial cells. But since their overall effect is to reduce the density of blood vessels, the ability of those agents to normalize tumor vasculature may not last long," says Fukumura. "Blocking nonvascular NO production and maintaining NO levels around the vessels appears to keep endothelial cell function at the proper level." An associate professor of Radiation Oncology at Harvard Medical School, Fukumura notes that the strategy now should be investigated in other types of tumors.
Massachusetts General Hospital
Blood Vessels News and Current Blood Vessels Events RSSNew oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancers
The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results in mice, report researchers from Children's Hospital Boston.
Watermelon May Have Viagra-Effect
A cold slice of watermelon has long been a Fourth of July holiday staple. But according to recent studies, the juicy fruit may be better suited for Valentine's Day.
UIC researchers make promising finding in severe lung disease
Researchers at the University of Illinois at Chicago have identified a novel function for an enzyme that plays a role in the tissue injury in acute respiratory distress syndrome, also known as ARDS.
A single mechanism for hypertension, insulin resistance and immune suppression
Many of the 75 million Americans with essential hypertension also develop diabetes and other complications in addition to their high blood pressure, and researchers have discovered a common molecular mechanism in a strain of rat that explains why such metabolic disorders arise together in mammals.
Pregnancy may help protect against bladder cancer
Pregnancy seems to confer some protection against bladder cancer in mice, scientists have found.
Scientists find how neural activity spurs blood flow in the brain
New research from Harvard University neuroscientists has pinpointed exactly how neural activity boosts blood flow to the brain. The finding has important implications for our understanding of common brain imaging techniques such as fMRI, which uses blood flow in the brain as a proxy for neural activity.
Certain anticancer agents could be harmful to patients with heart disease
A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis.
Severe retinal hemorrhaging is linked to severe motor vehicle crashes
The severity of retinal hemorrhaging for young children in motor vehicle crashes is closely correlated to the severity of the crash, according to a new study by researchers at the Medical College of Wisconsin in Milwaukee.
Study in Circulation provides detail on how low blood flow promotes vascular disease
Researchers have found the first direct proof that a key protein drives the clogging of arteries in two ways, and that lowering levels of it opens them up, according to study results published in the June edition of the journal Circulation.
New paradigm for cell-specific gene delivery
Researchers from Northwestern University and Texas A & M University have discovered a new way to limit gene transfer and expression to specific tissues in animals.
More Blood Vessels News Articles
 | Introduction to Vascular Ultrasonography(Fifth Edition) by William Zwiebel, John Pellerito |
 | Operative Dictations in General and Vascular Surgery: Operative Dictations Made Simple |
 | General and Vascular Ultrasound: Case Review Series (Case Review) by William D. Middleton |
 | Vascular and Interventional Radiology: The Requisites by John A. Kaufman, Michael J. Lee |
 | Diagnostic Cerebral Angiography by Anne G Osborn |
 | Vascular Technology: An Illustrated Review by Claudia Rumwell, Michalene McPharlin |
 | Introduction to Vascular Scanning: A Guide for the Complete Beginner (Introductions to Vascular Technology)(3rd Edition) by Donald P. Ridgway |
 | Atlas of Vascular Anatomy: An Angiographic Approach by Renan Uflacker |
 | Vascular Medicine: A Companion to Braunwald's Heart Disease by Mark A. Creager, Victor J. Dzau, Joseph Loscalzo |
 | Vascular Surgery, 2-vol set by Robert B. Rutherford |
| © 2008 BrightSurf.com |